Jonathan Wadsley
Weston Park Cancer Centre(GB)Sheffield Teaching Hospitals NHS Foundation Trust(GB)
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Thyroid Cancer Diagnosis and Treatment, Neuroendocrine Tumor Research Advances, Cancer Genomics and Diagnostics, Gastric Cancer Management and Outcomes
Most-Cited Works
- → Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial(2017)1,902 cited
- → Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study(2019)1,194 cited
- → Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial(2013)725 cited
- → Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial(2021)725 cited
- → Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer(2012)610 cited
- → Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial